Evidence map›Paper›PMID 32577250›Full record

ArticleClinical case reports2020

Therapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter-related infection treated with amikacin.

Sanae Kojya, Hideo Shiohira, Yoshitsugu Sunagawa, Shoji Tsuneyoshi, Kentaro Kohagura, Yusuke Ohya, Fusako Yonaha, Nobuo Hokama, Katsunori Nakamura

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sanae KojyaDepartment of Pharmacy University of the Ryukyus Hospital Okinawa Japan.
Hideo ShiohiraDepartment of Pharmacy University of the Ryukyus Hospital Okinawa Japan.ORCID https://orcid.org/0000-0002-0445-606X
Yoshitsugu SunagawaDepartment of Cardiovascular Medicine, Nephrology and Neurology Graduate School of Medicine University of the Ryukyus Okinawa Japan.
Shoji TsuneyoshiDialysis Unit University of the Ryukyus Hospital Okinawa Japan.
Kentaro KohaguraDialysis Unit University of the Ryukyus Hospital Okinawa Japan.
Yusuke OhyaDepartment of Cardiovascular Medicine, Nephrology and Neurology Graduate School of Medicine University of the Ryukyus Okinawa Japan.
Fusako YonahaDepartment of Pharmacy University of the Ryukyus Hospital Okinawa Japan.
Nobuo HokamaDepartment of Pharmacy University of the Ryukyus Hospital Okinawa Japan.
Katsunori NakamuraDepartment of Pharmacy University of the Ryukyus Hospital Okinawa Japan.ORCID https://orcid.org/0000-0003-0754-410X
University of the Ryukyus University Hospital · JPUniversity of the Ryukyus · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentrations in patients receiving CAPD.

Indexed as

amikacinnontuberculous mycobacteriumperitoneal dialysistherapeutic drug monitoring

Identifiers

PMID32577250
PMCPMC7303865
OpenAlexW3011486341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.